vTv Therapeutics (VTVT) EBT (2014 - 2026)
vTv Therapeutics (VTVT) posted EBT of $24.1 million for Q1 2026, up 438.11% sequentially from -$7.1 million in Q4 2025, and up 488.19% YoY from $4.1 million in Q1 2025.
vTv Therapeutics (VTVT) EBT (2014 - 2026) Analysis & Trends
vTv Therapeutics has reported EBT for 13 years, with the latest figure at $24.1 million in Q1 2026.
- Quarterly EBT rose 488.19% year-over-year to $24.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$729000.0 (up 96.82% YoY) and the FY2025 annual result came in at -$31.1 million, down 37.49% from the prior year.
- EBT climbed to $24.1 million in Q1 2026 per VTVT's latest filing, from -$7.1 million in the prior quarter.
- Over five years, EBT peaked at $24.1 million in Q1 2026 and troughed at -$10.3 million in Q3 2025.
- A 5-year average of -$4.7 million and a median of -$6.1 million in 2022 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2026: EBT sank 386.44% in 2022, then soared 488.19% in 2026.
- Over 5 years, EBT stood at -$6.1 million in 2022, then grew by 27.08% to -$4.4 million in 2023, then advanced by 0.09% to -$4.4 million in 2024, then slumped by 60.87% to -$7.1 million in 2025, then soared by 438.11% to $24.1 million in 2026.
- According to Business Quant data, EBT over the past three periods registered $24.1 million, -$7.1 million, and -$10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - | -13.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.05 Mn |
| Mar 31, 2026 | 24.13 Mn |
| Dec 31, 2025 | -7.14 Mn |
| Sep 30, 2025 | -10.35 Mn |
| Jun 30, 2025 | -7.38 Mn |
| Mar 31, 2025 | -6.22 Mn |
| Dec 31, 2024 | -4.44 Mn |
| Sep 30, 2024 | -5.84 Mn |
| Jun 30, 2024 | -6.41 Mn |
| Mar 31, 2024 | -5.92 Mn |
| Dec 31, 2023 | -4.44 Mn |
| Sep 30, 2023 | -8.54 Mn |
| Jun 30, 2023 | -7.21 Mn |
| Mar 31, 2023 | -5.77 Mn |
| Dec 31, 2022 | -6.09 Mn |
| Sep 30, 2022 | -5.47 Mn |
| Jun 30, 2022 | -4.09 Mn |
| Mar 31, 2022 | -9.22 Mn |
| Dec 31, 2021 | -9.48 Mn |
| Sep 30, 2021 | -1.37 Mn |